U.S. judge stands by ruling to limit evidence in Roundup cancer trials

  • 📰 TODAYonline
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 99%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 1. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

US judge stands by ruling to limit evidence in Roundup cancer trialsA federal judge overseeing lawsuits alleging Bayer AG's glyphosate-based Roundup weed killer causes cancer on Friday declined to reconsider a ... SarasotaMermaid To think that there are still people out there that trust corporations & the government more than common sense is mind boggling 😔 Cancer is a global epidemic no one talks about.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

US judge limits evidence in trial over Roundup cancer claimsA federal judge overseeing lawsuits alleging Bayer AG's glyphosate-based weed killer causes cancer has issued a ruling that could severely ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

US judge partially blocks Trump administration birth control rulesREUTERS: A judge in California on Sunday partially blocked a set of Trump administration rules that allow employers to opt out of providing health ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Lilly's cancer therapy Lartruvo fails to meet main goal in late-stage trialREUTERS: Eli Lilly and Co said on Friday its cancer treatment Lartruvo failed to meet the main goal in a late-stage trial testing the therapy in ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Lilly cancer drug fails key trial, will no longer be prescribedEli Lilly and Co said on Friday that its cancer treatment Lartruvo, which had won conditional approval, failed to improve patient survival in a ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Bristol-Myers beefs up cancer portfolio with US$74 billion Celgene buyCancer drugmaker Bristol-Myers Squibb Co said on Thursday it would buy Celgene Corp for about US$74 billion in a cash-and-stock deal.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »